Antitumor 1-nitroacridine derivative C-1748, induces apoptosis, necrosis or senescence in human colon carcinoma HCT8 and HT29 cells
- 1 May 2010
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 79 (9) , 1231-1241
Abstract
No abstract availableKeywords
Funding Information
- State Committee for Scientific Research (3PO5A11824)
This publication has 22 references indexed in Scilit:
- Accelerated senescence: An emerging role in tumor cell response to chemotherapy and radiationBiochemical Pharmacology, 2008
- Pre-clinical evaluation of 1-nitroacridine derived chemotherapeutic agent that has preferential cytotoxic activity towards prostate cancerCancer Biology & Therapy, 2007
- Cellular senescence: when bad things happen to good cellsNature Reviews Molecular Cell Biology, 2007
- Preclinical toxicological examination of a putative prostate cancer-specific 4-methyl-1-nitroacridine derivative in rodentsAnti-Cancer Drugs, 2007
- Pre-clinical toxicology and pathology of 9-(2′-hydroxyethylamino)-4-methyl-1-nitroacridine (C-1748), a novel anti-cancer agent in male Beagle dogsLife Sciences, 2006
- Comparative analysis of mutagenic potency of 1-nitro-acridine derivativesLife Sciences, 2005
- Escape from Therapy-Induced Accelerated Cellular Senescence in p53-Null Lung Cancer Cells and in Human Lung CancersCancer Research, 2005
- Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cellBiochemical Pharmacology, 2004
- Nitracrine and its congeners—An overviewGeneral Pharmacology: The Vascular System, 1995
- The mode of action of cytotoxic and antitumor 1-nitroacridines. III. In vivo interstrand cross-linking of DNA of mammalian or bacterial cells by 1-nitroacridinesChemico-Biological Interactions, 1983